BPH Holmium Laser

Surgical excellence, redefined.

With more than 14 randomized controlled trials, spanning more than a decade, it is no surprise that the AUA and EAU both support HoLVP and HoLEP as a first line procedure for the treatment of BPH. Precise and controlled cutting and ablation allows the holmium laser energy to penetrate just enough to ablate tissue without the charring, deep thermal necrosis or collateral damage often seen with other laser treatments.

Explore Products

Proven Procedures For The Desired Clinical Outcome


Holmium Laser Enucleation of the Prostate
Proven effective for prostates of all sizes

Learn More


Holmium Laser Ablation of the Prostate
Proven effective for small to medium prostates

Learn More

“I have been researching MOSES for BPH and I have found significant improvement in procedure time and hemostasis time,
This clear, measurable clinical value translated into treating more patients each day in my practice and the team and I are grateful for that.
With this new technology we have been successful in transitioning the majority of our HoLEP procedures to same day discharge home.
I look forward to publishing these results soon.”

Dr. Amy E. Krambeck, Northwestern Medicine
Dr. Amy E. Krambeck

BPH with MOSES technology:

  • 43% faster enucleation2
  • 54% faster hemostasis2
  • 90% same day, catheter free procedure1
  • 80% less fiber burnback2
  • Faster learning curve
  • Significant economic value

Want to learn more?

Get clinical information, procedure videos,
detailed brochure and more..

Lumenis Urology Devices


  1. Deepak K. Agarwal a, Tim Large a, Yan Tong b, Christa L. Stoughton a, Erica M. Damler a, Charles U. Nottingham a, Marcelino E. Rivera a, Amy E. Krambeck a. Same Day Discharge is a Successful Approach for the Majority of Patients Undergoing Holmium Laser Enucleation of the Prostate. Eur Urol Focus (2021), https://doi.org/10.1016/j.euf.2020.12.018
  2. Nevo A, Faraj KS, Cheney SM, Moore JP, Stern KL, Borofsky M, Gnessin E, Humphreys, at. el Holmium laser enucleation of the prostate using Moses 2.0 vs non-Moses. A randomized controlled trial. BJU Int. 2020
  3. Bristol B Whiles MD, Wilson R Molina MD, Kerri L Thurmon MD. Urology S0090-4295(20)31530-2, doi: 10.1016/j.urology.2020.12.024.

PB-00026060 Rev A